iRadimed
IRMD
145 hedge funds and large institutions have $340M invested in iRadimed in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 37 reducing their positions, and 15 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 37
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
14% more capital invested
Capital invested by funds: $300M → $340M (+$40.5M)
4% more funds holding
Funds holding: 139 → 145 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.42% less ownership
Funds ownership: 53.89% → 53.47% (-0.42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.6M |
| 2 |
Goldman Sachs
New York
|
+$3.6M |
| 3 |
Teacher Retirement System of Texas
Austin,
Texas
|
+$2.62M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.07M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$2.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bares Capital Management
Austin,
Texas
|
-$12.5M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$7.47M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.48M |
| 4 |
Renaissance Technologies
New York
|
-$956K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$952K |
IRMD Hedge Fund Activity: Q3 2024 in Review
145 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2024, worth a combined $340M — up 14% from $300M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new IRMD positions and 15 closed out — a net gain of 6 holders — while 64 added to existing stakes and 37 trimmed.
The largest buyer was BlackRock, adding an estimated $5.6M. The largest seller was Bares Capital Management, exiting entirely with an estimated $12.5M sold.
- 145 institutional investors held iRadimed (IRMD) as of Q3 2024, up from 139 in Q2 2024.
- Funds reported $340M of iRadimed stock for Q3 2024, up 14% quarter-over-quarter.
- 21 funds opened new iRadimed positions in Q3 2024 and 15 closed out, a net change of +6 holders.
- The largest iRadimed buyer in Q3 2024 was BlackRock, an estimated $5.6M added.
- The largest iRadimed seller in Q3 2024 was Bares Capital Management, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2024.